Company Overview
About Abridge
Abridge is a Pittsburgh, Pennsylvania-based healthcare AI clinical documentation platform — backed with approximately $800 million in total funding including a $300 million Series E in June 2025 led by Andreessen Horowitz and Khosla Ventures at a $5.3 billion valuation, following a $250 million Series D just four months prior at a $2.8 billion valuation — providing physicians, nurses, and care teams at 150+ health systems with AI that automatically converts patient-clinician conversations into structured clinical notes, saving physicians an average of 3 hours daily and generating high-quality documentation from UPMC (scaling to 12,000 clinicians enterprise-wide), Mayo Clinic, Johns Hopkins, and Emory Healthcare. Abridge's AI is trained on a proprietary dataset of over 1.5 million medical encounters, delivering specialty-specific documentation through deep Epic EHR integration. Founded in 2018 by cardiologist Dr. Shiv Rao.
Business Model & Competitive Advantage
Abridge's ambient clinical documentation platform addresses the documentation burden that drives physician burnout and reduces time available for patient care: physicians spend 35-55% of clinical time on EHR documentation — writing SOAP notes, filling structured encounter data, and completing the after-visit summary — work that occurs before the patient arrives (reviewing records), during the visit (real-time note typing), and after the patient leaves (completing notes, often at home after hours). Abridge's ambient AI (listening to the patient-physician conversation with consent, processing the clinical content, and generating a structured note in the physician's documentation style within minutes of the encounter completing) eliminates the concurrent typing burden and post-visit documentation backlog — returning physicians to eye contact and conversation with patients rather than screen-focused data entry, while generating more complete and accurate notes than manual documentation under time pressure.
Competitive Landscape 2025–2026
In 2025, Abridge competes in the ambient clinical AI, healthcare documentation, and physician productivity market with Nuance DAX (Microsoft, NASDAQ: MSFT, ambient clinical AI, largest ambient AI deployment), Suki AI (clinical voice assistant, $70M raised), and Nabla (ambient clinical documentation, $30M raised) for hospital system, health network, and multi-specialty physician group AI clinical documentation and ambient capture platform adoption. The $5.3 billion valuation (Series E, June 2025) places Abridge among the most valuable healthcare AI companies globally. UPMC's 12,000-clinician enterprise deployment demonstrates health system confidence at the scale of the nation's largest integrated health system. The Epic integration advantage (Abridge notes generating directly in Epic workflows with automatic field population) creates the EHR workflow integration that becomes switching-cost-protected once deployed. The 2025 strategy focuses on expanding from physician notes into nursing documentation and care coordinator workflows, building the AI-powered coding accuracy layer (improving ICD-10 code capture from documented encounters), and growing the international health system deployment in the UK NHS and Canadian health authorities.
The Abridge Story
Founders
Company Timeline
Major milestones in Abridge's journey
Leadership Team
Meet the leaders behind Abridge
Shiv Rao, MD
Practicing cardiologist at UPMC who founded Abridge in 2018. Previously led UPMC's provider investment portfolio and helped fund CMU's Machine Learning in Health program. Named to Time's 100 Most Influential People in AI.
Shiv's Clinical Team
Abridge employs multiple physicians in leadership roles to ensure clinical accuracy and relevance of AI documentation across specialties from cardiology to emergency medicine.
Open Positions
Reddit Discussions
Key Differentiators
Emerging Innovator
Abridge is an emerging player bringing innovative solutions to the Healthcare market.
Enterprise Scale
With $5300M in revenue, Abridge operates at enterprise scale with proven market validation.
Frequently Asked Questions
Not So Random Others
Hermes Robotics
Hermes Robotics is an autonomous mobile robot (AMR) and warehouse automation company developing robots and software for logistics and fulfillment operations in warehouses, distribution centers, and ma
Duckie
Duckie is a San Francisco-based AI customer support platform — backed by Y Combinator (W24) with $500,000 in funding from Y Combinator, Andreessen Horowitz, Greylock, KungHo Fund, Netflix, and 5 addit
Oda Studio
Oda Studio is a United States-based AI-powered interior design platform — backed by Y Combinator (W20) — providing homebuyers, renters, and design enthusiasts with AI tools to discover their personal
Bucket Robotics
Bucket Robotics is an autonomous mobile robot (AMR) company that designs modular, rapidly deployable robots for warehouse automation and industrial material handling. Unlike traditional warehouse auto
Cursor
Cursor is an AI-powered code editor built on Visual Studio Code that integrates advanced language models to provide intelligent code completion, generation, debugging, and refactoring capabilities dir
Zeffy
Zeffy is a Montreal-based fundraising platform for nonprofit organizations that charges zero platform fees on donations — asking donors to optionally contribute a tip to cover Zeffy's operating costs
Compare Abridge with Competitors
Side-by-side AI visibility scores, platform breakdown, and market position.
Claim This Profile
Are you from Abridge? Claim your profile to see full AI mention excerpts, get weekly visibility change alerts, and optimize how AI systems describe your brand.
Claim Abridge Profile →Track AI Visibility in Real Time
Monitor how ChatGPT, Gemini, Perplexity, and Claude mention Abridge vs competitors. Get alerts when AI recommendations shift.
Start Free Tracking →